Skip to main content
Clinical Trials/NL-OMON41007
NL-OMON41007
Withdrawn
Not Applicable

Identifying genetic determinants of Familial Barrett*s esophagus and adenocarcinoma of the gastro-esophageal junction - IFAMBAR study

Maag-, Darm- en Leverziekten0 sites60 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
adenocarcinoma of the gastro-esophageal junction
Sponsor
Maag-, Darm- en Leverziekten
Enrollment
60
Status
Withdrawn
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
Maag-, Darm- en Leverziekten

Eligibility Criteria

Inclusion Criteria

  • As described earlier, we identified in a collaborative effort (with the Departments of Surgery and Medical Genetics) 20 index patients from families that fulfill the criteria for familial BE or adenocarcinoma of the GEJ. Apart from the retrospectively identified index patient, new index patients identified during this study by the department of Medical Genetics will also be eligible for this study,;The criteria for familial BE or adenocarcinoma of the GEJ:
  • A. Two or more first\- or second degree relatives with BE or adenocarcinoma of the GEJ, with at least one diagnosed before the age of 50
  • B. Three or more first\- or second degree relatives with BE or adenocarcinoma of the GEJ, irrespective of age
  • C. One patient with BE or adenocarcinoma of the GEJ \< 40 yrs;For this study, individuals that meet the following inclusion criteria are eligible:
  • All first degree relatives (i.e. sons, daughters, sisters, brothers and father and mother of the index patient) of the index patient

Exclusion Criteria

  • A potential individual who meets any of the following criteria will be excluded from participation in this study:
  • 1\) Individuals \< 25 and \> 75 years old
  • 2\) Unable to fill out questionnaire

Outcomes

Primary Outcomes

Not specified

Similar Trials